Although some of the studies began to focus on the adverse effects of SGLT2 inhibitors such as infections, osmotic diuresis, ketoacidosis, acute kidney injury, and so on,[6–10] there is still lack of studies to evaluate the overall adverse effects about SGLT2 inhibitors. The gene discussed is SLC5A2; the disease is infection.